Search Results - "Sando, Yasuhisa"
-
1
Reduced dose of PTCy followed by adjuvant α-galactosylceramide enhances GVL effect without sacrificing GVHD suppression
Published in Scientific reports (23-06-2021)“…Posttransplantation cyclophosphamide (PTCy) has become a popular option for haploidentical hematopoietic stem cell transplantation (HSCT). However,…”
Get full text
Journal Article -
2
Extending Treatment Intervals of R-CHOP Therapy Might Be Acceptable for Some Patients with Non-indolent Non-Hodgkin's B-cell Lymphoma
Published in Acta medica Okayama (01-02-2022)“…R-CHOP therapy is generally performed every 3 weeks. We investigated the effects of extending the interval of R-CHOP therapy for > 1 week on the prognoses of…”
Get full text
Journal Article -
3
-
4
Author Correction: 5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy
Published in Scientific reports (15-03-2021)“…An amendment to this paper has been published and can be accessed via a link at the top of the paper…”
Get full text
Journal Article -
5
5-aminolevulinic acid-mediated photodynamic therapy can target aggressive adult T cell leukemia/lymphoma resistant to conventional chemotherapy
Published in Scientific reports (14-10-2020)“…Photodynamic therapy (PDT) is an emerging treatment for various solid cancers. We recently reported that tumor cell lines and patient specimens from adult T…”
Get full text
Journal Article -
6
Pretransplant nivolumab further enhanced Treg expansion after posttransplant cyclophosphamide; another aspect for immune tolerance by PTCy after nivolumab
Published in Leukemia (01-03-2021)Get full text
Journal Article -
7
Responses of regulatory and effector T-cells to low-dose interleukin-2 differ depending on the immune environment after allogeneic stem cell transplantation
Published in Frontiers in immunology (02-08-2022)“…CD4 + Foxp3 + regulatory T cells (Tregs) play a central role in the maintenance of immune tolerance after allogeneic hematopoietic stem cell transplantation…”
Get full text
Journal Article -
8
Long-term outcomes in patients treated in the intensive care unit after hematopoietic stem cell transplantation
Published in International journal of hematology (01-12-2018)“…The number of patients who are successfully discharged from the intensive care unit (ICU) after hematopoietic stem cell transplantation (HSCT) remains limited…”
Get full text
Journal Article -
9
Chemotherapy Improved Pulmonary Arterial Hypertension in a Patient with Chronic-Active Epstein-Barr Virus Infection
Published in International Heart Journal (31-01-2020)“…Chronic-active Epstein-Barr virus infection (CAEBV) is a rare disease that can lead to pulmonary arterial hypertension (PAH). However, the treatment for…”
Get full text
Journal Article -
10
Persistent hypogammaglobulinemia due to immunoglobulin class switch impairment by peri-transplant rituximab therapy
Published in International journal of hematology (01-09-2020)“…Post-transplant lymphoproliferative disorder (PTLD) is one of the most serious complications of allogeneic hematopoietic stem cell transplantation (HSCT)…”
Get full text
Journal Article -
11
Efficacy of HLA virtual cross‐matched platelet transfusions for platelet transfusion refractoriness in hematopoietic stem cell transplantation
Published in Transfusion (Philadelphia, Pa.) (01-03-2020)“…BACKGROUND Cross‐matched platelet (cross‐matched PLT) transfusion is effective for immune‐mediated platelet transfusion refractoriness (PTR), but is more…”
Get full text
Journal Article -
12
PTCy ameliorates GVHD by restoring regulatory and effector T-cell homeostasis in recipients with PD-1 blockade
Published in Blood advances (10-12-2019)“…Graft-versus-host disease (GVHD) after allogeneic hematopoietic stem cell transplantation (allo-HSCT) is a significant cause of morbidity and mortality…”
Get full text
Journal Article -
13
Hematopoietic stem cell-derived Tregs are essential for maintaining favorable B cell lymphopoiesis following posttransplant cyclophosphamide
Published in JCI insight (24-04-2023)“…Posttransplant cyclophosphamide (PTCy) is associated with a low incidence of chronic graft-versus-host disease (cGVHD) following hematopoietic stem cell (HSC)…”
Get full text
Journal Article -
14
Donor Treg expansion by liposomal α‐galactosylceramide modulates Tfh cells and prevents sclerodermatous chronic graft‐versus‐host disease
Published in Immunity, Inflammation and Disease (01-09-2021)“…Background and Aim Chronic graft‐versus‐host disease (cGVHD) is a major cause of nonrelapse morbidity and mortality following hematopoietic stem cell…”
Get full text
Journal Article -
15
Total body irradiation-based haploidentical hematopoietic stem cell transplantation using posttransplant cyclophosphamide after administration of inotuzumab ozogamicin: A case report
Published in Leukemia research reports (01-01-2021)“…Owing to the poor prognosis of relapsed or refractory acute lymphoblastic leukemia (ALL), hematopoietic stem cell transplantation (HSCT) followed by effective…”
Get full text
Journal Article -
16
Successful treatment with azacitidine for myelodysplastic syndrome with large vessel vasculitis
Published in Rinshō ketsueki (01-01-2015)“…Paraneoplastic inflammation of the large vessels is a rare complication of myelodysplastic syndrome (MDS), and patients with MDS and systemic vasculitis have a…”
Get more information
Journal Article -
17
PD-1 modulates regulatory T-cell homeostasis during low-dose interleukin-2 therapy
Published in Blood (13-04-2017)“…CD4+Foxp3+ regulatory T cells (Tregs) play a central role in the maintenance of immune tolerance after hematopoietic stem cell transplantation. We previously…”
Get full text
Journal Article -
18
Posttransplant Cyclophosphamide Promote Naïve-Subset Dominant B Cell Recovery Coordinated with Early Treg Expansion; Implication of Reduced Risk of Pathogenesis into Chronic Gvhd
Published in Blood (29-11-2018)“…Posttransplant cyclophosphamide (PTCy) is an effective prophylaxis for both acute and chronic graft-versus-host disease (GVHD) after allogeneic hematopoietic…”
Get full text
Journal Article -
19
Post-Transplant Cyclophosphamide Ameliorates Lethal Thymic GVHD By Restoring Regulatory and Effector T Cell Homeostasis in Recipients with Prior PD-1 Blockade Therapy
Published in Blood (29-11-2018)“…Allogeneic HSCT has a curative potential for patients with hematological malignancies. However, graft-versus-host disease (GVHD) remains to be a significant…”
Get full text
Journal Article -
20
Effectiveness of supplemental oral calcium drink in preventing citrate-related adverse effects in peripheral blood progenitor cell collection
Published in Transfusion and apheresis science (01-08-2021)“…•Hypocalcemia can occur even under intravenous calcium gluconate in PBPC apheresis.•The addition of oral calcium drinks reduced frequency of citrate acid…”
Get full text
Journal Article